Search Results 271-280 of 701 for ������������������������ ������������KaKaotalk:PC53���24������ ���������������

  1. Mayo Clinic Q & A - Dr. Gregory Poland - COVID- 19 Update Tra...

    Our thanks to Mayo Clinic infectious disease and virology expert, Dr. Greg Poland. Thanks so much Dr. Poland. Dr. Gregory Poland 24:46. My pleasure. DeeDee.

  2. Health Topics - Mayo Clinic News Network

    On this week's episode of Tomorrow's Cure, we explore brain-computer interfaces (BCIs), cutting-edge technologies that create direct communication pathways ...

  3. Novel cholangiopancreatoscope with a large rotating channel for pancreatobiliary disorders - Mayo Clinic

    The study will recruit patients undergoing ERCP with diagnostic and therapeutic interventions as part of routine clinical care for pancreaticobiliary diseaseTo ...

  4. A Study To Evaluate The Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderate To Severe Crohn's Disease (MK-7240-008) - Mayo Clinic

    Rochester, Minnesota: 24-008233. NCT ID: NCT06430801. Sponsor Protocol Number: Protocol Number: 008-00. About this study. The purpose of this protocol is to ...

  5. Publications

    AN UNUSUAL CAUSE OF HYPERCALCEMIA AND NEPHROCALCINOSIS DURING PREGNANCY-CYP24A1 DEFICIENCY AMERICAN JOURNAL OF KIDNEY DISEASES (Vol. 85, No. 4). 2025. Kizilbash ...

  6. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

    CC-220-MM-001: A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, ...

  7. Health Topics - Mayo Clinic News Network

    On this week's episode of Tomorrow's Cure, we explore brain-computer interfaces (BCIs), cutting-edge technologies that create direct communication pathways ...

  8. Health Topics - Mayo Clinic News Network

    On this week's episode of Tomorrow's Cure, we explore brain-computer interfaces (BCIs), cutting-edge technologies that create direct communication pathways ...

  9. A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial - Mayo Clinic

    Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from ...

  10. Publications

    2019 Nov; 60 (11):2712-2719 Epub 2019 Apr 24. View PubMed; Dyrbye LN, Awad KM, Fiscus LC, Sinsky CA, Shanafelt TD. Estimating the Attributable Cost of ...